2023 - Research.com Biology and Biochemistry in Sweden Leader Award
His scientific interests lie mostly in Platelet-derived growth factor receptor, Platelet-derived growth factor, Molecular biology, Receptor and Growth factor. His research brings together the fields of Cancer research and Platelet-derived growth factor. His research integrates issues of Integrin and Immunology, Arthritis in his study of Molecular biology.
His Integrin research integrates issues from Fibronectin, Extracellular matrix and Cell adhesion. His Receptor study combines topics from a wide range of disciplines, such as Cancer, Cancer drugs and Endocrinology. His studies in Growth factor integrate themes in fields like Pericyte, Mesenchymal stem cell, Pathology, 3T3 cells and Fibroblast.
His primary areas of study are Pathology, Cell biology, Extracellular matrix, Molecular biology and Integrin. His biological study spans a wide range of topics, including Platelet-derived growth factor, Growth factor and Platelet-derived growth factor receptor. His Platelet-derived growth factor receptor research is included under the broader classification of Receptor.
His Cell biology study incorporates themes from Actin cytoskeleton and Interstitial fluid. His Molecular biology research includes themes of Fibroblast and Antibody. The Integrin study combines topics in areas such as Fibronectin and Focal adhesion.
Kristofer Rubin spends much of his time researching Extracellular matrix, Cell biology, Cancer research, Pathology and Immunology. The study incorporates disciplines such as Fibril, Integrin, Growth factor and Stromal cell in addition to Extracellular matrix. Kristofer Rubin studies Growth factor, focusing on Platelet-derived growth factor receptor in particular.
His Cell biology research is multidisciplinary, incorporating elements of Molecular biology and Biochemistry. His Cancer research study also includes
The scientist’s investigation covers issues in Immunology, Extracellular matrix, Fibril, Cell biology and Cancer research. Kristofer Rubin combines subjects such as Biophysics, Vascular permeability, Osmotic pressure, Interstitial fluid and Interstitial space with his study of Extracellular matrix. Fibril is a subfield of Biochemistry that he investigates.
Kristofer Rubin interconnects Molecular biology, Integrin, Thrombin and Fibrin in the investigation of issues within Cell biology. His study looks at the intersection of Cancer research and topics like Cancer with Angiogenesis, Endostatin and Receptor. His Connective tissue study is associated with Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
High interstitial fluid pressure — an obstacle in cancer therapy
Carl-Henrik Heldin;Kristofer Rubin;Kristian Pietras;Arne Östman.
Nature Reviews Cancer (2004)
Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types
Carl-Henrik Heldin;Gudrun Bäckström;Arne Östman;Annet Hammacher.
The EMBO Journal (1988)
Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors.
Kristian Pietras;Arne Östman;Mats Sjöquist;Elisabeth Buchdunger.
Cancer Research (2001)
PDGF receptors as cancer drug targets
Kristian Pietras;Tobias Sjöblom;Kristofer Rubin;Carl-Henrik Heldin.
Cancer Cell (2003)
Inhibition of PDGF Receptor Signaling in Tumor Stroma Enhances Antitumor Effect of Chemotherapy
Kristian Pietras;Kristofer Rubin;Tobias Sjöblom;Elisabeth Buchdunger.
Cancer Research (2002)
Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies.
Rikard Holmdahl;Kristofer Rubin;Lars Klareskog;Erik Larsson.
Arthritis & Rheumatism (1986)
Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF.
Donald Gullberg;Anders Tingström;Ann Charlotte Thuresson;Lennart Olsson.
Experimental Cell Research (1990)
INDUCTION OF B-TYPE RECEPTORS FOR PLATELET-DERIVED GROWTH FACTOR IN VASCULAR INFLAMMATION: POSSIBLE IMPLICATIONS FOR DEVELOPMENT OF VASCULAR PROLIFERATIVE LESIONS
Kristofer Rubin;Anders Tingström;Göran K Hansson;Erik Larsson.
The Lancet (1988)
T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones.
R. Holmdahl;L. Klareskog;K. Rubin;E. Larsson.
Scandinavian Journal of Immunology (1985)
Analysis of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrins in cell--collagen interactions: identification of conformation dependent alpha 1 beta 1 binding sites in collagen type I.
D. Gullberg;K.R. Gehlsen;D.C. Turner;K. Ahlén.
The EMBO Journal (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Uppsala University
Karolinska Institute
Karolinska Institute
Medical University of South Carolina
University of Bergen
Karolinska Institute
Texas A&M Health Science Center
Lund University
New York University
Karolinska Institute
Hong Kong University of Science and Technology
Columbia University
IBM (United States)
Jožef Stefan Institute
Sun Yat-sen University
Guilin University of Technology
University of Minnesota
Monash University
Umeå University
Human Genome Sciences (United States)
Southeast University
United States Food and Drug Administration
Centre national de la recherche scientifique, CNRS
Centre national de la recherche scientifique, CNRS
University of Minnesota
Washington University in St. Louis